119 related articles for article (PubMed ID: 7366196)
1. Cholecystokinin and gastric inhibitory polypeptide not glucagonotropic in dogs.
Sirinek KR; Levine BA; Crockett SE; Cataland S
J Surg Res; 1980 Apr; 28(4):367-72. PubMed ID: 7366196
[No Abstract] [Full Text] [Related]
2. Release of pancreatic and gastric somatostatin-like immunoreactivity in response to the octapeptide of cholecystokinin, secretin gastric inhibitory polypeptide, and gastrin-17 in dogs.
Rouiller D; Schusdziarra V; Harris V; Unger RH
Endocrinology; 1980 Aug; 107(2):524-9. PubMed ID: 6104593
[No Abstract] [Full Text] [Related]
3. Gastric inhibitory polypeptide, cholecystokinin, and secretin effects on insulin and glucagon secretion by islet cultures.
Fujimoto WY; Williams RH; Ensinck JW
Proc Soc Exp Biol Med; 1979 Mar; 160(3):349-53. PubMed ID: 372950
[No Abstract] [Full Text] [Related]
4. Reassessment of gastric acid inhibition by cholecystokinin and gastric inhibitory polypeptide in dogs.
Mayer EA; Elashoff J; Mutt V; Walsh JH
Gastroenterology; 1982 Nov; 83(5):1047-50. PubMed ID: 7117786
[TBL] [Abstract][Full Text] [Related]
5. Effects of cholecystokinin, secretin, and pancreatic polypeptide on secretion of gastric inhibitory polypeptide, insulin, and glucagon.
Williams RH; Champagne J
Life Sci; 1979 Sep; 25(11):947-56. PubMed ID: 513942
[No Abstract] [Full Text] [Related]
6. The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.
Ipp E; Dobbs RE; Harris V; Arimura A; Vale W; Unger RH
J Clin Invest; 1977 Nov; 60(5):1216-9. PubMed ID: 908761
[TBL] [Abstract][Full Text] [Related]
7. Augmented gastric inhibitory polypeptide response to intraduodenal glucose by exogenous gastrin and cholecystokinin.
Sirinek KR; Cataland S; O'Dorisio TM; Mazzaferri EL; Crockett SE; Pace WG
Surgery; 1977 Oct; 82(4):438-42. PubMed ID: 898020
[No Abstract] [Full Text] [Related]
8. Pancreatic alpha- and beta-cell responses to GIP infusion in normal man.
Elahi D; Andersen DK; Brown JC; Debas HT; Hershcopf RJ; Raizes GS; Tobin JD; Andres R
Am J Physiol; 1979 Aug; 237(2):E185-91. PubMed ID: 464094
[No Abstract] [Full Text] [Related]
9. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
Szecówka J; Lins PE; Efendić S
Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
[TBL] [Abstract][Full Text] [Related]
10. Gut hormones and the alpha cell.
Bloom SR; Iversen J
Metabolism; 1976 Nov; 25(11 Suppl 1):1457-8. PubMed ID: 790093
[No Abstract] [Full Text] [Related]
11. Effect of a combination of gastrin, secretin, cholecystokinin, glucagon, and gastric inhibitory polypeptide on jejunal absorption in man.
Poitras P; Modigliani R; Bernier JJ
Gut; 1980 Apr; 21(4):299-304. PubMed ID: 7429291
[TBL] [Abstract][Full Text] [Related]
12. Effect of cholecystokinin, gastrin, secretin and GIP on sham feeding in the rat.
Lorenz DN; Kreielsheimer G; Smith GP
Physiol Behav; 1979 Dec; 23(6):1065-72. PubMed ID: 542516
[No Abstract] [Full Text] [Related]
13. Actions of natural gastric inhibitory peptide on pancreatic acinar cells: due to contamination with cholecystokinin.
Jensen RT; Lemp GF; Beinfeld MC; Gardner JD
Gastroenterology; 1982 Jan; 82(1):20-5. PubMed ID: 6171476
[No Abstract] [Full Text] [Related]
14. Effects of motilin and octapeptide of cholecystokinin on antral and duodenal myoelectric activity in the interdigestive state and during inhibition by secretin and gastric inhibitory polypeptide.
Castresana M; Lee KY; Chey WY; Yajima H
Digestion; 1978; 17(4):300-8. PubMed ID: 669076
[TBL] [Abstract][Full Text] [Related]
15. Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake.
Young AA; Gedulin BR; Rink TJ
Metabolism; 1996 Jan; 45(1):1-3. PubMed ID: 8544764
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of gastric inhibitory polypeptide (GIP) as the enterogastrone.
Soon-Shiong P; Debas HT; Brown JC
J Surg Res; 1979 Jun; 26(6):681-6. PubMed ID: 156287
[No Abstract] [Full Text] [Related]
17. Inhibition of actions of glucagon in adipocytes by gastric inhibitory polypeptide.
Dupre J; Greenidge N; McDonald TJ; Ross SA; Rubinstein D
Metabolism; 1976 Nov; 25(11):1197-9. PubMed ID: 185484
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of gastric secretion by i.v. gastric inhibitory polypeptide (GIP) in man (author's transl)].
Schafmayer A; Becker HD; Börger HW; Coelle EF; Arnold R; Creutzfeldt W
Chir Forum Exp Klin Forsch; 1980; ():208-12. PubMed ID: 7389456
[TBL] [Abstract][Full Text] [Related]
19. Effects of gastrointestinal hormones on concentrating function and motility in the gallbaldder. An experimental study in the cat.
Jansson R
Acta Physiol Scand Suppl; 1978; 456():1-38. PubMed ID: 278473
[No Abstract] [Full Text] [Related]
20. Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas.
Pederson RA; Brown JC
Endocrinology; 1978 Aug; 103(2):610-5. PubMed ID: 744105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
